-+ 0.00%
-+ 0.00%
-+ 0.00%

HARBOUR BIOMED RECEIVES CHINA NMPA APPROVAL OF BATOCLIMAB INJECTION (SUBCUTANEOUS INJECTION) FOR THE TREATMENT OF GENERALIZED MYASTHENIA GRAVIS

Reuters·10/23/2026 00:03:13

Please log in to view news